Overview: Thyroglobulin TestIntroduction: The Thyroglobulin Test measures thyroglobulin to diagnose thyroid cancer, causing neck swelling. Following 2023 ATA guidelines, it uses biochemical methods for high specificity, supporting cancer screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in endocrinology for patients with suspected thyroid cancer.
Other Names: Thyroglobulin Assay, Tg Test.
FDA Status: Laboratory-developed test (LDT), meeting endocrinology standards for diagnostic accuracy.
Historical Milestone: Thyroglobulin testing began in the 1970s with thyroid cancer research. Biochemical methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Measures thyroglobulin to diagnose thyroid cancer, guides treatment, and evaluates patients with neck swelling.
Test Parameters: 1. Thyroglobulin Level
Pretest Condition: Fasting for 10-12 hours required. Collect serum or plasma. Report history of neck swelling or thyroid symptoms.
Specimen: Serum (SST, 2-5 mL), Plasma (EDTA, 2-4 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document neck swelling, thyroid nodules, or history of thyroid cancer. Include current medications, especially thyroid hormone therapy.
Consent: Written consent required, detailing the tests purpose, thyroid cancer implications, and risks of sample collection.
Procedural Considerations: Uses enzyme-linked immunosorbent assay (ELISA) or chemiluminescence to measure thyroglobulin levels. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for thyroid cancer diagnosis.
Factors Affecting Result Accuracy: Improper fasting or sample hemolysis can affect results. Thyroglobulin antibodies may cause false negatives.
Clinical Significance: Elevated thyroglobulin confirms thyroid cancer, guiding surgery or radioactive iodine therapy. Normal levels may require ultrasound or biopsy.
Specialist Consultation: Consult an endocrinologist or oncologist for result interpretation and treatment planning.
Additional Supporting Tests: Thyroid ultrasound, fine-needle aspiration, or thyroglobulin antibodies to confirm thyroid cancer diagnosis.
Test Limitations: Non-specific in the presence of thyroglobulin antibodies; clinical correlation is needed. Sample quality affects sensitivity.
References: ATA Thyroid Cancer Guidelines, 2023; Journal of Clinical Endocrinology, Haugen BR, 2022.
